Filtered By:
Drug: Aspirin

This page shows you your search results in order of relevance. This is page number 4.

Order by Relevance | Date

Total 8741 results found since Jan 2013.

Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial
Conclusions Extended DAPT did not achieve superiority in reducing net adverse clinical events compared to 12 months of DAPT after DES placement. The power of the OPTIDUAL trial was however low and reduced by premature termination of enrolment. ClinicalTrials.gov number NCT00822536.
Source: European Heart Journal - January 21, 2016 Category: Cardiology Authors: Helft, G., Steg, P. G., Le Feuvre, C., Georges, J.-L., Carrie, D., Dreyfus, X., Furber, A., Leclercq, F., Eltchaninoff, H., Falquier, J.-F., Henry, P., Cattan, S., Sebagh, L., Michel, P.-L., Tuambilangana, A., Hammoudi, N., Boccara, F., Cayla, G., Douard, Tags: ESC Hot Line Source Type: research

Does continued aspirin mono-therapy lead to a higher bleeding risk after total knee arthroplasty?
ConclusionDespite the slightly higher risks of bleeding, continuing aspirin mono-therapy during TKA might be safe with low risks of perioperative cerebrovascular, cardiovascular, and venous thromboembolic events.
Source: Journal of the Chinese Medical Association - September 9, 2018 Category: General Medicine Source Type: research

Cancers, Vol. 11, Pages 1639: Antiplatelet Agents for Cancer Prevention: Current Evidences and Continuing Controversies
et Cancer Over the past two decades, aspirin has emerged as a promising chemoprotective agent to prevent colorectal cancer (CRC). In 2016, the mounting evidence supporting its chemoprotective effect, from both basic science and clinical research, led the US Preventive Services Task Force to recommend regular use of low-dose aspirin in some subgroups of patients for whom the benefits are deemed to outweigh the risks. In contrast, data on the chemoprotective effect of aspirin against other cancers are less clear and remain controversial. Most data come from secondary analyses of cardiovascular prevention trials, with on...
Source: Cancers - October 23, 2019 Category: Cancer & Oncology Authors: Corinne Frere Manon Lejeune Pierre Kubicek Doroth ée Faille Zora Marjanovic the Groupe Francophone Thrombose et Cancer Tags: Review Source Type: research

Effects of continuing use of aspirin on blood loss in patients who underwent unilateral total knee arthroplasty.
CONCLUSION: Patients who underwent TKA with continuation of low-dose aspirin did not result in more blood loss. Current blood loss management has provided sufficient reduction of blood loss to accommodate aspirin therapy perioperatively. We suggest that it is safe to continue aspirin prior to TKA. PMID: 31916487 [PubMed - in process]
Source: Journal of Orthopaedic Surgery - December 31, 2019 Category: Orthopaedics Authors: Hang G, Chen JY, Yew AKS, Pang HN, Jin DTK, Chia SL, Lo NN, Yeo SJ Tags: J Orthop Surg (Hong Kong) Source Type: research

How the Ban on Medical Advertising Hurt Women Doctors
This article was published on JSTOR Daily, read the original article here.
Source: TIME: Health - October 16, 2019 Category: Consumer Health News Authors: Olivia Campbell / JSTOR Daily Tags: Uncategorized health medicine onetime syndication Source Type: news

Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology
Objective: To assess evidence regarding periprocedural management of antithrombotic drugs in patients with ischemic cerebrovascular disease. The complete guideline on which this summary is based is available as an online data supplement to this article. Methods: Systematic literature review with practice recommendations. Results and recommendations: Clinicians managing antithrombotic medications periprocedurally must weigh bleeding risks from drug continuation against thromboembolic risks from discontinuation. Stroke patients undergoing dental procedures should routinely continue aspirin (Level A). Stroke patients underg...
Source: Neurology - May 27, 2013 Category: Neurology Authors: Armstrong, M. J., Gronseth, G., Anderson, D. C., Biller, J., Cucchiara, B., Dafer, R., Goldstein, L. B., Schneck, M., Messe, S. R. Tags: Ultrasound, All Medical/Systemic disease, All Neuro-ophthalmology, All Cerebrovascular disease/Stroke, All Trauma SPECIAL ARTICLE Source Type: research

Safety and efficacy of switching anticoagulation to aspirin three months after successful radiofrequency catheter ablation of atrial fibrillation.
CONCLUSION: Switching warfarin to aspirin 3 months after successful RFCA of AF could be as safe and efficacious as long-term anticoagulation even in patients with CHA₂DS₂-VASc score ≥2. However, strict rhythm monitoring cannot be overemphasized. PMID: 25048480 [PubMed - in process]
Source: Yonsei Medical Journal - July 25, 2014 Category: Universities & Medical Training Authors: Uhm JS, Won H, Joung B, Nam GB, Choi KJ, Lee MH, Kim YH, Pak HN Tags: Yonsei Med J Source Type: research

Automated processing of electronic medical records is a reliable method of determining aspirin use in populations at risk for cardiovascular events.
CONCLUSIONS: NLP of the EMR is accurate in ascertaining documented aspirin use and could potentially be used for epidemiological research as a source of cardiovascular risk factor information. PMID: 21078235 [PubMed - indexed for MEDLINE]
Source: Informatics in Primary Care - December 2, 2014 Category: Primary Care Tags: Inform Prim Care Source Type: research

Effectiveness of two kind of medicine on non-obstructive azoospermia
Conclusion The treatment of varococele is important for the NOA with varicocele while andriol and tamoxifen is other method for the treatment of idiopathic NOA.
Source: Australasian Medical Journal - AMJ - October 4, 2017 Category: General Medicine Source Type: research

Oral antiplatelets in primary and secondary prevention of myocardial infarction: a review
AbstractThere are a number of guidelines and articles available for the use of oral antiplatelets for primary and secondary prevention of myocardial infarction (MI). Antiplatelet medications inhibit platelet activation, aggregation, and other pathways eventually inhibiting clot formation. Aspirin and clopidogrel have been the mainstay in the management of acute coronary syndrome for about a decade. We have discussed the role of aspirin, clopidogrel, ticagrelor, and prasugrel which are the most commonly used oral antiplatelet medications in the current era. We have also considered the role of newer thrombin inhibitor vorapa...
Source: Irish Journal of Medical Science - September 3, 2018 Category: General Medicine Source Type: research

< em > Helicobacter pylori < /em > infection and the risk of upper gastrointestinal bleeding in low dose aspirin users: systematic review and meta-analysis.
CONCLUSIONS: The odds of upper gastrointestinal bleeding in patients taking low dose aspirin is about twice as great in those infected with H. pylori. Testing for and treating the infection should be considered in such patients, especially if their underlying risk of peptic ulcer bleeding is already high. PMID: 30257623 [PubMed - in process]
Source: Medical Journal of Australia - September 29, 2018 Category: General Medicine Tags: Med J Aust Source Type: research

Oral antiplatelets in primary and secondary prevention of myocardial infarction: a review
AbstractThere are a number of guidelines and articles available for the use of oral antiplatelets for primary and secondary prevention of myocardial infarction (MI). Antiplatelet medications inhibit platelet activation, aggregation, and other pathways eventually inhibiting clot formation. Aspirin and clopidogrel have been the mainstay in the management of acute coronary syndrome for about a decade. We have discussed the role of aspirin, clopidogrel, ticagrelor, and prasugrel which are the most commonly used oral antiplatelet medications in the current era. We have also considered the role of newer thrombin inhibitor vorapa...
Source: Irish Journal of Medical Science - September 3, 2018 Category: General Medicine Source Type: research

No Advantage From Aspirin in Preventing Preterm Preeclampsia No Advantage From Aspirin in Preventing Preterm Preeclampsia
The questions surrounding continuing or discontinuing aspirin in this high-risk population need further consideration.MDedge News
Source: Medscape Medical News Headlines - February 23, 2023 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

The relationship between aspirin consumption and hepatocellular carcinoma: a systematic review and meta-analysis
ConclusionAspirin may reduce the risk of HCC in both healthy population and patients with chronic liver disease. However, attention should be paid to adverse events such as gastrointestinal bleeding in patients with chronic liver disease.
Source: European Journal of Medical Research - July 8, 2023 Category: Research Source Type: research

Continuing Aspirin Causes Higher Drainage Even under Full Protection with Antifibrinolytics.
Conclusion Continuing aspirin before CABG is associated with increased blood loss even when used in small doses and under full cover of antifibrinolytic agents. However, this blood loss is not harmful and does not negatively affect the patient's clinical progress. PMID: 23344762 [PubMed - as supplied by publisher]
Source: The Thoracic and Cardiovascular Surgeon - January 23, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Al-Lawati AA, Muthuswamy V Tags: Thorac Cardiovasc Surg Source Type: research